Gilead Sciences, Inc.
CH ˙ SWX ˙ US3755581036
SecurityCH:GILD / Gilead Sciences, Inc.
InstitutionEvergreen Capital Management Llc
Latest Disclosed Ownership28,292 shares
Latest Disclosed Value $ 3,943,114
Evergreen Capital Management Llc reports 9.88% increase in ownership of GILD / Gilead Sciences, Inc.

On May 14, 2026 - Evergreen Capital Management Llc filed a 13F-HR form disclosing ownership of 28,292 shares of Gilead Sciences, Inc. (CH:GILD) valued at $3,943,114 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 27, 2026 disclosing 25,747 shares of Gilead Sciences, Inc.. This represents a change in shares of 9.88% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F GILEAD SCIENCES COM 375558103 28,292 2,545 9.88 3,943 24.78 0.0670
2026-01-27 2025-12-31 13F GILEAD SCIENCES COM 375558103 25,747 398 1.57 3,160 12.34 0.0706
2025-10-28 2025-09-30 13F GILEAD SCIENCES COM 375558103 25,349 1,277 5.30 2,814 5.43 0.0669
2025-08-14 2025-06-30 13F GILEAD SCIENCES COM 375558103 24,072 3,393 16.41 2,669 15.15 0.0803
2025-05-15 2025-03-31 13F GILEAD SCIENCES COM 375558103 20,679 -109 -0.52 2,317 20.68 0.0778
2025-02-13 2024-12-31 13F GILEAD SCIENCES COM 375558103 20,788 1 0.00 1,920 10.22 0.0625
2024-11-14 2024-09-30 13F GILEAD SCIENCES COM 375558103 20,787 406 1.99 1,743 24.61 0.0585
2024-08-14 2024-06-30 13F GILEAD SCIENCES COM 375558103 20,381 -622 -2.96 1,398 -9.10 0.0506
2024-05-15 2024-03-31 13F GILEAD SCIENCES COM 375558103 21,003 -1,107 -5.01 1,538 -14.13 0.0582
2024-02-14 2023-12-31 13F GILEAD SCIENCES COM 375558103 22,110 501 2.32 1,791 10.62 0.0732
2023-11-14 2023-09-30 13F GILEAD SCIENCES COM 375558103 21,609 -1,689 -7.25 1,619 -9.81 0.0710
2023-08-14 2023-06-30 13F GILEAD SCIENCES COM 375558103 23,298 2,289 10.90 1,796 2.98 0.0750
2023-05-15 2023-03-31 13F GILEAD SCIENCES COM 375558103 21,009 562 2.75 1,743 -0.68 0.0783
2023-02-14 2022-12-31 13F GILEAD SCIENCES COM 375558103 20,447 1,323 6.92 1,755 48.85 0.0825
2022-11-14 2022-09-30 13F GILEAD SCIENCES COM 375558103 19,124 14,853 347.76 1,179 346.59 0.0616
2022-08-15 2022-06-30 13F GILEAD SCIENCES COM 375558103 4,271 671 18.64 264 23.36 0.0137
2022-05-16 2022-03-31 13F GILEAD SCIENCES COM 375558103 3,600 -1,652 -31.45 214 -43.83 0.0087
2022-03-11 2021-12-31 13F GILEAD SCIENCES COM 375558103 5,252 -432 -7.60 381 -4.03 0.0153
2021-11-15 2021-09-30 13F GILEAD SCIENCES COM 375558103 5,684 1,353 31.24 397 33.22 0.0179
2021-08-16 2021-06-30 13F GILEAD SCIENCES COM 375558103 4,331 189 4.56 298 11.19 0.0142
2021-05-17 2021-03-31 13F GILEAD SCIENCES COM 375558103 4,142 4,142 268 0.0137
2020-11-16 2020-09-30 13F GILEAD SCIENCES COM 375558103 0 -2,775 -100.00 0 -100.00
2020-08-14 2020-06-30 13F GILEAD SCIENCES COM 375558103 2,775 2,775 214 0.0162
2020-05-15 2020-03-31 13F GILEAD SCIENCES COM 375558103 0 -3,665 -100.00 0 -100.00
2020-02-14 2019-12-31 13F GILEAD SCIENCES COM 375558103 3,665 358 10.83 238 13.33 0.0198
2019-11-14 2019-09-30 13F GILEAD SCIENCES COM 375558103 3,307 153 4.85 210 -1.41 0.0196
2019-08-14 2019-06-30 13F GILEAD SCIENCES COM 375558103 3,154 3,154 213 0.0203
2019-02-14 2018-12-31 13F GILEAD SCIENCES COM 375558103 0 -3,070 -100.00 0 -100.00
2018-11-13 2018-09-30 13F GILEAD SCIENCES COM 375558103 3,070 187 6.49 237 16.18 0.0210
2018-08-13 2018-06-30 13F GILEAD SCIENCES COM 375558103 2,883 -8,827 -75.38 204 -76.90 0.0191
2018-05-10 2018-03-31 13F GILEAD SCIENCES COM 375558103 11,710 -40,475 -77.56 883 -76.38 0.0848
2018-02-14 2017-12-31 13F GILEAD SCIENCES COM 375558103 52,185 3,025 6.15 3,738 -6.15 0.3781
2017-11-09 2017-09-30 13F GILEAD SCIENCES COM 375558103 49,160 6,280 14.65 3,983 31.24 0.4658
2017-08-08 2017-06-30 13F GILEAD SCIENCES COM 375558103 42,880 11,385 36.15 3,035 41.89 0.4894
2017-05-10 2017-03-31 13F GILEAD SCIENCES COM 375558103 31,495 -2,680 -7.84 2,139 -12.59 0.4454
2017-02-08 2016-12-31 13F GILEAD SCIENCES COM 375558103 34,175 34,175 2,447 0.4727
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.